Movicol Pediátrico Chocolate, Saqueta

Macrogol 3350, the active ingredient in Movicol Pediátrico Chocolate, is an osmotic laxative presented as a powder for solution (sachet) for oral use. It treats constipation in pediatric patients by increasing water content in the intestinal lumen. GNH USA supplies Movicol Pediátrico Chocolate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Pediátrico Chocolate is an osmotic laxative used to manage constipation in children. - Constipation: softens stool and facilitates regular bowel movements in pediatric patients. - Functional constipation: improves stool frequency and consistency in children with chronic functional bowel disorders. - Encopresis secondary to constipation: helps resolve fecal leakage by relieving impacted stool.

Macrogol 3350 may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas leading to discomfort. - Nausea: mild feeling of queasiness. - Diarrhoea: loose stools occurring if the dose is excessive.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal levels of sodium, potassium, or chloride. - Severe abdominal pain: persistent or worsening pain requiring medical assessment.

Before using Movicol Pediátrico Chocolate, consider the following precautions. - Renal impairment: monitor fluid and electrolyte status in children with kidney dysfunction. - Cardiac disease: assess risk of fluid overload in patients with heart conditions. - Gastrointestinal obstruction: avoid use if a mechanical blockage is suspected. - Dehydration: ensure adequate hydration to prevent excessive fluid loss. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Macrogol 3350 can interact with other medications, affecting absorption or electrolyte balance.

Major Interactions (Avoid): - Lithium: concurrent use may increase lithium serum concentrations, risking toxicity. - Digoxin: altered absorption may affect digoxin levels, requiring monitoring.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: may reduce the laxative effect. - Diuretics: combined use may exacerbate electrolyte disturbances.